- Gautam, N, Alamoudi JA, Kumar S, Alnouti, Y. Quantification of Intracellular Nucleotide Metabolites by LC-MS. J Pharm Biomed Anal. 2019 Oct 3;178:112902. doi: 10.1016/j.jpba.2019.112902. [Epub ahead of print]. PMID: 31610397.
- Banoub MG, Bade AN, Lin Z, Cobb D, Gautam N, Dyavar Shetty BL, Wojtkiewicz M, Alnouti Y, McMillan J, Gendelman HE, Edagwa B. Synthesis and Characterization of Long-Acting Darunavir Prodrugs. Mol Pharm. 2020 Jan 6;17(1):155-166. doi: 10.1021/acs.molpharmaceut.9b00871. Epub 2019 Dec 3. PMID: 31742407.
- Saraswathi V, Heineman R, Alnouti Y, Shivaswamy V, Desouza CV. A combination of Omega-3 PUFAs and COX inhibitors: A novel strategy to manage obesity-linked dyslipidemia and adipose tissue inflammation. J Diabetes Complications. 2019 Nov 22:107494. doi: 10.1016/j.jdiacomp.2019.107494. [Epub ahead of print]. PMID: 31787562.
- Smith N, Bade AN, Soni D, Gautam N, Alnouti Y, Herskovitz J, Ibrahim IM, Wojtkiewicz MS, Dyavar Shetty BL, McMillan J, Gendelman HE, Edagwa B. A long acting nanoformulated lamivudine ProTide. Biomaterials. 2019 Sep 5;223:119476. doi: 10.1016/j.biomaterials. PMID: 31525692.
- Ibrahim IM, Bade AN, Lin Z, Soni D, Wojtkiewicz M, Dyavar Shetty BL, Gautam N, McMillan JM, Alnouti Y, Edagwa BJ, Gendelman HE. Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation. Int J Nanomedicine. 2019 Aug 7;14:6231-6247. doi: 10.2147/IJN.S215447. PMID: 31496683, PMCID: PMC6689761.
- Dyavar SR, Gautam N, Podany AT, Winchester LC, Weinhold JA, Mykris TM, Campbell KM, Alnouti Y, Fletcher CV. Assessing the lymphoid tissue bioavailability of antiretrovirals in human primary lymphoid endothelial cells and in mice. J Antimicrob Chemother. 2019 Jul 23. pii: dkz273. doi: 10.1093/jac/dkz273. PMID: 31335938.
- Soni D, Bade AN, Gautam N, Herskovitz J, Ibrahim IM, Smith N, Wojtkiewicz MS, Dyavar Shetty BL, Alnouti Y, McMillan J, Gendelman HE, Edagwa BJ. Synthesis of a long acting nanoformulated emtricitabine ProTide. Biomaterials. 2019 Aug 20;222:119441. doi: 10.1016/j.biomaterials.2019.119441. PMID: 31472458.
- Hilaire JR, Bade AN, Sillman B1, Gautam N, Herskovitz J, Shetty BLD, Wojtkiewicz MS, Szlachetka A, Lamberty B, Sravanam S, Fox H, Alnouti Y, Dash PK, McMillan JM, Edagwa BJ, Gendelman HE. Creation of a long-acting rilpivirine prodrug nanoformulation. J Control Release. 2019 Sep 3. pii: S0168-3659(19)30534-6. doi: 10.1016/j.jconrel.2019.09.001. [Epub ahead of print]. PMID: 31491432.
- Sharma S, Kozek KA, Abney KK, Kumar S, Gautam N, Alnouti Y, David Weaver C, Hopkins CR. Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators. Bioorg Med Chem Lett. 2019 Mar 15;29(6):791-796. doi: 10.1016/j.bmcl.2019.01.027. Epub 2019 Jan 23. PMID: 30718161. PMCID: PMC6398930.
- McMillan J, Szlachetka A, Zhou T, Morsey B, Lamberty B, Callen S, Gautam N, Alnouti Y, Edagwa B, Gendelman HE, Fox HS. Pharmacokinetic testing of a first generation cabotegravir prodrug in rhesus macaques. AIDS. 2019 Mar 1; 33(3): 585-588. DOI: 10.1097/QAD.0000000000002032. PMID: 30289818.
- Lin Z, Gautam N, Alnouti Y, McMillan J, Bade AN, Gendelman HE, Edagwa B. ProTide generated long-acting abacavir nanoformulations. Chem Commun (Camb). 2018 Jul 24; 54 (60): 8371-8374. PMID: 29995046. PMCID: PMC6063073.
- Thakare R, Alamoudi JA, Gautam N, Rodrigues AD, Alnouti Y. Species differences in bile acids II. Bile acid metabolism. J Appl Toxicol. 2018 Oct; 38(10):1336-1352. PMID: 29845631.
- Thakare R, Alamoudi JA, Gautam N, Rodrigues AD, Alnouti Y. Species differences in bile acids I. Plasma and urine bile acid composition. J Appl Toxicol. 2018 Oct; 38(10):1323-1335. [Epub ahead of print]. PMID: 29785833.
- Zhou T, Lin Z, Puligujja P, Palandri D, Hilaire J, Araínga M, Smith N, Gautam N, McMillan J, Alnouti Y, Liu X, Edagwa B, Gendelman HE. Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals. Nanomedicine (Lond). 2018 Mar 19. PMID: 29553879. PMCID: PMC5992566.
- Gautam N, Lin Z, Banoub MG, Smith NA, Maayah A, McMillan J, Gendelman HE, Alnouti Y. Simultaneous quantification of intracellular lamivudine and abacavir triphosphate metabolites by LC-MS/MS. J Pharm Biomed Anal. 2018 May 10;153:248-259. PMID: 29518644, PMCID: PMC5860827. Featured by Technology Networks in the area of "Advances and Innovations in Metabolite Quantitation by LC-MS/MS" on May 2018.
- Sillman B, Bade AN, Dash PK, Bhargavan B, Kocher T, Mathews S, Su H, Kanmogne GD, Poluektova LY, Gorantla S, McMillan J, Gautam N, Alnouti Y, Edagwa B, Gendelman HE. Creation of a long-acting nanoformulated dolutegravir. Nat Commun. 2018 Feb 6;9(1):443. PMID: 29402886. PMCID: PMC5799307.
- Hartmann P, Hochrath K, Horvath A, Chen P, Seebauer CT, Llorente C, Wang L, Alnouti Y, Fouts DE, Stärkel P, Loomba R, Coulter S, Liddle C, Yu RT, Ling L, Rossi SJ, DePaoli AM, Downes M, Evans RM, Brenner DA, Schnabl B. Modulation of the intestinal bile acid-FXR-FGF15 axis improves alcoholic liver disease in mice. Hepatology. 2018 Jun; 67(6):2150-2166. PMID: 29159825. PMCID: PMC5962369.
- Thakare R, Chhonker YS, Gautam N, Nelson A, Casaburi R, Criner G, Dransfield MT, Make B, Schmid KK, Rennard SI, Alnouti Y. Simultaneous LC-MS/MS analysis of eicosanoids and related metabolites in human serum, sputum and BALF. Biomed Chromatogr. 2018 Mar;32(3). PMID: 28975688. PMCID: PMC6003856.
- Kindel TL, Krause C, Helm M3, McBride CL, Oleynikov D, Thakare R, Alamoudi J, Kothari V, Alnouti Y, Kohli R. Increased glycine-amidated hyocholic acid correlates to improved early weight loss after sleeve gastrectomy. Surg Endosc. 2018 Feb;32(2):805-812. PMID: 28779240. PMCID: PMC5844265.
- Zhou T, Su H, Dash P, Lin Z, Dyavar Shetty BL, Kocher T, Szlachetka A, Lamberty B, Fox HS, Poluektova L, Gorantla S, McMillan J, Gautam N, Mosley RL, Alnouti Y, Edagwa B, Gendelman HE. Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles. Biomaterials. 2018 Jan;151: 53-65. PMID: 29059541. PMCID: PMC5926202.
- McMillan J, Szlachetka A, Slack L, Sillman B, Lamberty B, Morsey B, Callen S, Gautam N, Alnouti Y, Edagwa B, Gendelman HE, Fox HS. Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques. Antimicrob Agents Chemother. 2017 Dec 21;62(1). PMID: 29061742. PMCID: PMC5740312.
- Bowden JA, Heckert A, Ulmer CZ, Jones CM, Koelmel JP, Abdullah L, Ahonen L, Alnouti Y, Armando AM, Asara JM, …,Zhou S. Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in Frozen Human Plasma. J Lipid Res. 2017 Dec; 58(12):2275-2288. PMID: 28986437. PMCID: PMC5711491.
- Thakare R, Gao H1, Kosa RE, Bi YA, Varma MVS, Cerny MA, Sharma R, Kuhn M, Huang B, Liu Y, Yu A, Walker GS, Niosi M, Tremaine L, Alnouti Y, Rodrigues AD. Leveraging of Rifampicin-Dosed Cynomolgus Monkeys to Identify Bile Acid 3-O-Sulfate Conjugates as Potential Novel Biomarkers for Organic Anion-Transporting Polypeptides. Drug Metab Dispos. 2017 Jul;45(7):721-733. PMID: 28396527.
- Wei X, Li F, Zhao G, Chhonker YS, Averill C, Galdamez J, Purdue PE, Wang X, Fehringer EV, Garvin KL, Goldring SR, Alnouti Y, Wang D. Pharmacokinetic and Biodistribution Studies of HPMA Copolymer Conjugates in an Aseptic Implant Loosening Mouse Model. Mol Pharm. 2017 May 1;14(5):1418-1428. PMID: 28343392.
- Guo D, Zhou T, Araínga M, Palandri D, Gautam N, Bronich T, Alnouti Y, McMillan J, Edagwa B, Gendelman HE. Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine. J Acquir Immune Defic Syndr. 2017 Mar. 74(3): e75-e83. PMID: 27559685. PMCID: PMC5305294.
- Gnanadhas DP, Dash PK, Sillman B, Bade AN, Lin Z, Palandri DL, Gautam N, Alnouti Y, Gelbard HA, McMillan J, Mosley RL, Edagwa B, Gendelman HE, Gorantla S. Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs. J Clin Invest. 2017 Mar 1. 127(3): 857-873. PMID: 28134625. PMCID: PMC5330738.
- Saraswathi V, Perriotte-Olson C, Ganesan M, Desouza CV, Alnouti Y, Duryee MJ, Thiele GM, Nordgren TM, Clemens DL. A combination of dietary N-3 fatty acids and a cyclooxygenase-1 inhibitor attenuates nonalcoholic fatty liver disease in mice. J Nutr Biochem. 2017 April;42:149-159. PMID: 28187366.
- Yang Z, Liu Y, Ahn J, Qiao Z, Endres JL, Gautam N, Huang Y, Li J, Zheng J, Alnouti Y, Bayles KW, Li R. Novel fluorinated pyrrolomycins as potent anti-staphylococcal biofilm agents: Design, synthesis, pharmacokinetics and antibacterial activities. Eur J Med Chem. 2016 Aug. 124: 129-137. PMID: 27565555.
- Singh D, McMillan J, Hilaire J, Gautam N, Palandri D, Alnouti Y, Gendelman HE, Edagwa B. Development and characterization of a long-acting nanoformulated abacavir prodrug. Nanomedicine (Lond). 2016 Aug. 11 (15): 1913-27. PMID: 27344632. PMCID: PMC4996153.
- Thakare R, Chhonker YS, Gautam N, Alamoudi JA, Alnouti Y. Quantitative analysis of endogenous compounds. J Pharm Biomed Anal. 2016 Sep. 128:426-37. PMID: 27456759.
- Coiro P, Padmashri R, Suresh A, Spartz E, Pendyala G, Chou S, Jung Y, Meays B, Roy S, Gautem N, Alnouti Y, Li M, Dunaevsky A. Impaired synaptic development in a maternal immune activation mouse model of neurodevelopmental disorders. Brain Behav Immun. 2015 Nov. 50:249-258. PMID: 26218293. PMCID: PMC4955953.
- Nagsen Gautam, Rhishikesh Thakare, Sandeep Rana, Amarnath Natarajan, Yazen Alnouti. Irreversible Binding of an Anticancer Compound (BI-94) to Plasma Proteins. Xenobiotica. 2015 Oct, 45 (10): 858-73. PMID: 25869245. PMCID: PMC4553108.
- Cerutis DR1, Weston MD, Alnouti Y, Bathena SP, Nunn ME, Ogunleye AO, McVaney TP, Headen KV, Miyamoto T. A Major Human Oral Lysophosphatidic Acid Species, LPA 18:1, Regulates Novel Genes in Human Gingival Fibroblasts. J Periodontol. 2015 May, 86 (5):713-25. PMID: 25660500.
- Bathena SP, Thakare R, Gautam N, Mukherjee S, Olivera M, Meza J, Alnouti Y. Urinary Bile Acids as Biomarkers for Liver Diseases II. Signature Profiles in Patients. Toxicol Sci. 2015 Feb, 143 (2): 308-18. PMID: 25344563.
- Bathena SP, Thakare R, Gautam N, Mukherjee S, Olivera M, Meza J, Alnouti Y. Urinary Bile Acids as Biomarkers for Liver Diseases I. Stability of the baseline profile in healthy subjects. Toxicol Sci. 2015 Feb, 143 (2): 296-307. PMID: 25344562.
- Gautam N, Puligujja P, Balkundi S, Thakare R, Liu XM, Fox HS, McMillan J, Gendelman HE, Alnouti Y. Pharmacokinetics, Biodistribution, and Toxicity of Folic Acid-Coated Antiretroviral Nanoformulations. Antimicrob Agents Chemother. 2014 Oct 6. pii: AAC.04108-14. PMID: 25288084. PMCID: PMC4249580. Featured by MDlinx in the area of Infectious Diseases on Dec 2014. Featured by World Biomedical Frontiers in the area of Infection and Immunity on Sep 2015 (http://biomedfrontiers.org/inf-2015-9-8/).
- Wang L, Hartmann P, Haimerl M, Bathena SP, Sjöwall C, Almer S, Alnouti Y, Hofmann AF, Schnabl B. Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids. J Hepatol. 2014 Jun; 60(6): 1259-67. PMID: 24560660. PMCID: PMC4028388.
- Bathena SP, Mukherjee S, Olivera M, Alnouti Y. The profile of bile acids and their sulfate metabolites in human urine and serum. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Dec; 942-943:53-62. PMID: 24212143. Not directly supported by NIH.
- Epstein AA, Narayanasamy P, Dash PK, High R, Bathena SP, Gorantla S, Poluektova LY, Alnouti Y, Gendelman HE, Boska MD. Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection. J NeuroimmunePharmacol. 2013 Dec; 8(5): 1224-38. PMCID: PMC3889226.
- Gautam N, Roy U, Balkundi S, Puligujja P, Guo D, Smith N, Liu XM, Lamberty B, Morsey B, Fox HS, McMillan J, Gendelman HE, Alnouti Y. Preclinical Pharmacokinetics and Tissue Distribution of Long-Acting Nanoformulated Antiretroviral Therapy. Antimicrob Agents Chemother. 2013 Jul; 57(7): 3110-20. PMID: 23612193. PMCID: PMC3697338. Featured by MDlinx in the area of Infectious Diseases on Dec 2013.
- Gautam N, Bathena SP, Chen Q, Natarajan A, Alnouti Y. Pharmacokinetics, protein binding and metabolism of a quinoxaline urea analog as an NF-κB inhibitor in mice and rats by LC-MS/MS. Biomed Chromatogr. 2013 Jul; 27(7): 900-9. PMCID: PMC3760428.
- Radhakrishnan P, Bryant VC, Blowers EC, Rajule RN, Gautam N, Anwar MM, Mohr AM, Grandgenett PM, Bunt SK, Arnst JL, Lele SM, Alnouti Y, Hollingsworth MA, Natarajan A. Targeting the NF-κB and mTOR Pathways with a Quinoxaline Urea Analog That Inhibits IKKβ for Pancreas Cancer Therapy. Clin Cancer Res. 2013 Apr 15; 19(8): 2025-35. PMCID: PMC3630250.
- Dash PK, Gendelman HE, Roy U, Balkundi S, Alnouti Y, Mosley RL, Gelbard HA, McMillan J, Gorantla S, Poluektova LY. Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice. AIDS. 2012 Nov 13; 26(17): 2135-44. PMCID: PMC4024396.
- Roy U, McMillan J, Alnouti Y, Gautum N, Smith N, Balkundi S, Dash P, Gorantla S, Martinez-Skinner A, Meza J, Kanmogne G, Swindells S, Cohen SM, Mosley RL, Poluektova L, Gendelman HE. Pharmacodynamic and antiretroviral activities of combination nanoformulatedantiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice. J Infect Dis. 2012 Nov 15; 206 (10): 1577-88. PMCID: PMC3570176.
- Oberoi HS, Nukolova NV, Laquer FC, Poluektova LY, Huang J, Yokohira M, Arnold LL, Kabanov AV, Cohen SM, Bronich TK, Alnouti Y. Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice. Int J Nanomedicine. 2012; 7:2557-71. PMCID: PMC3383348.
- Kanmogne GD, Singh S, Roy U, Liu X, McMillan J, Gorantla S, Balkundi S, Smith N, Alnouti Y, Gautam N, Zhou Y, Poluektova L, Kabanov A, Bronich T, Gendelman HE. Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells. IntJ Nanomedicine. 2012; 7:2373-88. PMCID: PMC3357981.
- Bathena SP, Huang J, Epstein AA, Gendelman HE, Boska MD, Alnouti Y. Rapid and reliable quantitation of amino acids and myo-inositol in mouse brain by high performance liquid chromatography and tandem mass spectrometry. J Chromatogr B AnalytTechnol Biomed Life Sci. 2012 Apr 15; 893-894: 15-20. PMCID: PMC3322302.
- Flynn CA, Alnouti Y, Reed GA. Quantification of the transporter substrate fexofenadine in cell lysates by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2011 Aug 30; 25(16): 2361-6. PMCID: PMC4076838.
- Huang J, Gautam N, Bathena SP, Roy U, McMillan J, Gendelman HE, Alnouti Y. UPLC-MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues. J Chromatogr B AnalytTechnol Biomed Life Sci. 2011 Aug 1; 879(23): 2332-8. PMCID: PMC3144699.
- Bathena SP, Huang J, Nunn ME, Miyamoto T, Parrish LC, Lang MS, McVaney TP, Toews ML, Cerutis DR, Alnouti Y. Quantitative determination of lysophosphatidic acids (LPAs) in human saliva and gingival crevicular fluid (GCF) by LC-MS/MS. J Pharm Biomed Anal. 2011 Sep 10; 56(2): 402-7. PMCID: PMC3134166.
- Gor P, Alnouti Y, Reed GA. Buspirone, fexofenadine, and omeprazole: quantification of probe drugs and their metabolites in human plasma. J Pharm Biomed Anal. 2011 Jul 15; 55(5): 1127-35. PMCID: PMC3100389.
- Huang J, Bathena SP, Csanaky IL, Alnouti Y. Simultaneous characterization of bile acids and their sulfate metabolites in mouse liver, plasma, bile, and urine using LC-MS/MS. J Pharm Biomed Anal. 2011 Jul 15; 55(5): 1111-9. PMID: 21530128. Not directly supported by NIH.
- Alnouti Y, Klaassen CD. Mechanisms of gender-specific regulation of mouse sulfotransferases (Sults). Xenobiotica. 2011 Mar; 41(3):187-97. PMID: 21091322.
- Huang J, Bathena SP, Alnouti Y. Metabolite profiling of praziquantel and its analogs during the analysis of in vitro metabolic stability using information-dependent acquisition on a hybrid triple quadrupole linear ion trap mass spectrometer. Drug MetabPharmacokinet. 2010; 25(5): 487-99. PMID: 20877135. Not directly supported by NIH.
- Quan LD, Yuan F, Liu XM, Huang JG,Wang D, Alnouti Y. Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl) methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model. Mol Pharm. 2010 Aug 2; 7(4): 1041-9. PMCID: PMC2914173.
- Dong Y, Chollet J, Vargas M, Mansour NR, Bickle Q, Alnouti Y, Huang J, Keiser J, Vennerstrom JL. Praziquantel analogs with activity against juvenile Schistosomamansoni. Bioorg Med ChemLett. 2010 Apr 15; 20(8): 2481-4. PMID: 20303754.
- Huang J, Bathena SP, Tong J, Roth M, Hagenbuch B, Alnouti Y. Kinetic analysis of bile acid sulfation by stably expressed human sulfotransferase 2A1 (SULT2A1). Xenobiotica. 2010 Mar; 40(3):184-94. PMID: 20102295. Not directly supported by NIH.
- Alnouti Y. Bile Acid sulfation: a pathway of bile acid elimination and detoxification. Toxicol Sci. 2009 Apr; 108(2): 225-46. PMID: 19131563. Not directly supported by NIH. Selected as “Exceptional” by “Faculty of 1000 Biology: the expert guide to the most important advances in biology”
- Alnouti Y, Csanaky IL, Klaassen CD. Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. J Chromatogr B AnalytTechnol Biomed Life Sci. 2008 Oct 1; 873(2): 209-17. PMCID: PMC2582521.
- Liu XM, Quan LD, Tian J, Alnouti Y, Fu K, Thiele GM, Wang D. Synthesis and evaluation of a well-defined HPMA copolymer-dexamethasone conjugate for effective treatment of rheumatoid arthritis. Pharm Res. 2008 Dec; 25(12): 2910-9. PMCID: PMC2593120.
- Alnouti Y, Klaassen CD. Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. Toxicol Sci. 2008 Jan; 101(1): 51-64. PMID: 17998271.
- Alnouti Y, Klaassen CD. Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice. J Pharmacol Exp Ther. 2008 Feb; 324(2): 612-21. PMID: 17993606.
- Alnouti YM, Shelby MK, Chen C, Klaassen CD. Influence of phenobarbital on morphine metabolism and disposition: LC-MS/MS determination of morphine (M) and morphine-3-glucuronide (M3G) in Wistar-Kyoto rat serum, bile, and urine. Curr Drug Metab. 2007 Jan; 8(1): 79-89. PMID: 17266525.
- Alnouti Y, Klaassen CD. Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol Sci. 2006 Oct; 93(2): 242-55. PMID: 16807285.
- Alnouti Y, Li M, Kavetskaia O, Bi H, Hop CE, Gusev AI. Method for internal standard introduction for quantitative analysis using on-line solid-phase extraction LC-MS/MS. Anal Chem. 2006 Feb 15; 78(4): 1331-6. PMID: 16478130.
- Alnouti Y, Petrick JS, Klaassen CD. Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab Dispos. 2006 Mar; 34(3): 477-82. PMID: 16381671.
- Alnouti Y, Srinivasan K, Waddell D, Bi H, Kavetskaia O, Gusev AI. Development and application of a new on-line SPE system combined with LC-MS/MS detection for high throughput direct analysis of pharmaceutical compounds in plasma. J Chromatogr A. 2005 Jul 8; 1080(2): 99-106. PMID: 16008047.
- Li M, Alnouti Y, Leverence R, Bi H, Gusev AI. .Increase of the LC-MS/MS sensitivity and detection limits using on-line sample preparation with large volume plasma injection. J Chromatogr B AnalytTechnol Biomed Life Sci. 2005 Oct 25; 825(2): 152-60. PMID: 15936252.
- Alnouti Y, Lewis SR, White CA, Bartlett MG. Simultaneous determination of zidovudine and lamivudine from rat tissues by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2005; 19(4): 503-8. PMID: 15678520.
- Alnouti Y, White CA, Bartlett MG. Simultaneous quantitation of zidovudine and zidovudine monophosphate from plasma, amniotic fluid and tissues by micellar capillary electrophoresis. Biomed Chromatogr. 2004 Oct; 18(8): 523-31. PMID: 15386521.
- Alnouti Y, White CA, Bartlett MG. Simultaneous determination of zidovudine and lamivudine from rat plasma, amniotic fluid and tissues by HPLC. Biomed Chromatogr. 2004 Nov;18 (9): 641-7. PMID: 15386504.
- Alnouti Y, White CA, Bartlett MG. Determination of lamivudine in plasma, amniotic fluid, and rat tissues by liquid chromatography. J Chromatogr B AnalytTechnol Biomed Life Sci. 2004 Apr 25; 803(2): 279-84. PMID: 15063336.
- Al-nouti Y, Bartlett MG. Comparison of local anesthetic-cyclodextrin non-covalent complexes using capillary electrophoresis and electrospray ionization mass spectrometry. J Am Soc Mass Spectrom. 2002 Aug; 13(8): 928-35. PMID: 12216733.
Book Chapters
Huangui Xiong and Howard E. Gendelman (2013). Current Laboratory Methods in Neuroscience Research. New York, NY, Springer, (ISBN-13: 978-1461487937). Chapter 52: Metabolomics, Y Alnouti: 425-451.
Huangui Xiong and Howard E. Gendelman (2013). Current Laboratory Methods in Neuroscience Research. New York, NY, Springer, (ISBN-13: 978-1461487937). Chapter 52: Metabolomics, Y Alnouti: 425-451.
Scientific Media Coverage
- NIDA (National Institute of Drug Abuse) Notes, Oct 8 2014, New Approach Uses Immune Cells To Deliver Anti-HIV Medications (http://www.drugabuse.gov/news-events/nida-notes/2014/10/new-approach-uses-immune-cells-to-deliver-anti-hiv-medications)
- UNMC News Room, Jan 20 2015, Meet Distinguished Scientist Yazen Alnouti, Ph.D. (http://www.unmc.edu/news.cfm?match=16340)